The Cancéropôle Grand Ouest is pleased to announce the first edition of the workshop “3D Bioprinting in Cancer Research” which will be held in Nantes on July 5 th, 2017.
Co-organized by CRCINA, Phy-Os and MicroPICell platform, this workshop aims to present this new technology, which is attracting a high interest in cancer research as it allows
the fabrication of living tissue as well as organs using cells and hydrogels in petri dishes,
the biofabrication of 3D tumor models with biomimetic cell/cell and cell/extracellular matrix interactions.
Mimicking the microenvironment of tumors using 3D Bioprinting will help the development of new therapies against cancers being an intermediate technology platform between traditional 2D monocellular cultures and animal models.
Focus will be made on the following items:
Hands-on workshops with bioprinters will be organized:
Several 3D bioprinters will be available for testing and demonstration.
Attendees can register for specific workshop
Symposium will be limited to 120 attendees.
Cancéropôle Grand Ouest is a vast network that associate scientists and health care professionals for the development of new tools for diagnosis and innovative treatments.
Since 2003, the cancéropôles have become part of the cancer research landscape in France enabling a better coordination of resources and means and breaking down barriers. They give rise to large-scale research networks and infrastructures fostering interdisciplinarity.
The 7 regional or interregional hubs named cancéropôles bring together research units of scientific institutions (Inserm, CNRS, universities, CEA, …), university hospitals, comprehensive cancer centers, pharmaceutical companies and biotech players.
Their goals are mainly:
(1) structure and coordinate research between institutions, at regional and inter-regional levels,
(2) define specific strategic orientations based on the fields of excellence of each Cancéropôle,
(3) create synergies with innovation and economic development stakeholders and
(4) ensure adequacy between regional and national R&D policies in oncology, as promoted by the french National Cancer Institute (INCa).
High-level quality research projects supported by the INCa and the Ministry of Health through the cancéropôles networks should allow to better understand the molecular mechanisms involved in oncogenesis which is crucial to define new therapeutic targets and to develop innovative treatments for the benefit of all patients.
More information : http://www.canceropole-grandouest.com